EarningsQ3 2022 Earnings Report

Novavax (NVAX) Q3 2022 Earnings Report

0 Followers

MX:NVAX Q3 2022 EPS Results

Actual EPS-$39.50

Consensus EPS$28.81

Beat/MissMissed by -$68.32

One Year Ago EPS-$79.19

Actual Revenue$13.50B

Expected Revenue$10.77B

Beat/MissBeat by +$2.73B

YoY Revenue Growth+310.74%

QuarterQ3 2022

Date11/08/2022

TimeAfter Close

Conference CallTuesday, November 8, 2022

MX:NVAX Upcoming Earnings

Novavax's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

MX:NVAX Q3 2022 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-3.97 / -	-22.968	―
Aug 06, 2026	2026 (Q2)	-6.98 / -5.88	11.392	-151.61% (-17.27)
May 06, 2026	2026 (Q1)	-4.45 / -1.10	53.837	-102.05% (-54.94)
Feb 26, 2026	2025 (Q4)	-8.91 / 2.02	-9.371	121.57% (+11.39)
Nov 06, 2025	2025 (Q3)	-21.98 / -22.97	-13.964	-64.47% (-9.00)
Aug 06, 2025	2025 (Q2)	0.15 / 11.39	18.191	-37.37% (-6.80)
May 08, 2025	2025 (Q1)	-7.77 / 53.84	-19.293	379.05% (+73.13)
Feb 27, 2025	2024 (Q4)	-9.44 / -9.37	-26.459	64.58% (+17.09)
Nov 12, 2024	2024 (Q3)	-14.53 / -13.96	-23.152	39.68% (+9.19)
Aug 08, 2024	2024 (Q2)	30.68 / 18.19	10.657	70.69% (+7.53)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed